Equipment and Processing Report
Companies manufacturing cytotoxic drugs must ensure that staff are given the highest possible levels of protection.
Ian Samson
Advertisement
Ian Samson is DuPont consultant for the EMEA and Russia regions, www.chemicalprotection.dupont.co.uk.
Articles by Ian Samson
It is vital that companies involved in the manufacturing and handling of cytotoxic drugs ensure that staff are given the highest possible levels of protection.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
PharmTech Weekly Roundup—June 19, 2026
4
Why the First Generic Single-Dose Flu Antiviral Approval Matters
5